Loading clinical trials...
Loading clinical trials...
An Open-label, Randomized, Single-dose, Two-period Crossover Design on Evaluating the Bioequivalence of Spironolactone Tablets 100mg (by SPH Sine Pharmaceutical Laboratories Co.,Ltd) and ALDACTONE® Tablets 100mg (by GD SEARLE LLC) in Healthy Adult Volunteers Under Fasting and Fed Conditions
Conditions
Interventions
Spironolactone Tablets (Test)
Spironolactone Tablets (Reference)
Locations
1
China
Shanghai Xuhui Central Hospital
Shanghai, Shanghai Municipality, China
Start Date
March 22, 2023
Primary Completion Date
May 5, 2023
Completion Date
August 23, 2023
Last Updated
August 30, 2024
NCT06969963
NCT06924190
NCT06600282
NCT06549504
NCT05436769
NCT04229602
Lead Sponsor
SPH Sine Pharmaceutical Laboratories Co., Ltd.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions